Lantern Pharma Inc. - Common Stock (NQ:LTRN)
All News about Lantern Pharma Inc. - Common Stock
Lantern Pharma Touts Encouraging Positive Efficacy For Pancreatic Cancer Candidate ↗
September 14, 2022
Via Benzinga
From Lantern Pharma Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
November 01, 2022
Via Benzinga
Lantern Pharma to Present at Upcoming Investor Conferences
October 05, 2022
From Lantern Pharma Inc.
Via Business Wire